Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
2h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
3h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
5h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
13h agoBuffalo Potash Files Annual Information Form and New Technical Report
14h agoIonik Announces 30-Day Extension of Senior Debt Facility
Hemostemix Inc logo

Hemostemix Inc

About

0.06CAD+0.00 +10.00%
Closed • Updated at 16:46 GMT+00:00
Market Cap$7.89M
Volume1.0K
Beta0.96
RSI38.26
Health TechnologyBiotechnology

Hemostemix Inc — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 9 2026
Hemostemix Leadership Attending Abundance360 Summit
Feb 3 2026
Hemostemix Appoints Renowned Vascular Surgeon and Principal Investigator, Dr. York Hsiang, as Business Consultant to Advance First Nations-Led Healthcare Partnerships
Jan 16 2026
Hemostemix Receives FDA Support for Its Basket Protocol Approach
Dec 31 2025
Hemostemix Closes $480,000 Private Placement at $0.12 per Share
Dec 23 2025
Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01

Community Chat

Ask AI

Try asking
6ix6ixAIEvents